Drug Approval | June 12, 2022
China NMPA approves Tislelizumab for metastatic nasopharyngeal cancer
Tislelizumab is now approved in nine indications in China
Tislelizumab is now approved in nine indications in China
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care
Pharmaceutical manufacturer uses Veeam solutions to accelerate mission-critical backups by 95% and restore data in minutes, not hours
The Da Vinci Robotic-Assisted Surgery system, and Advanced Robotic Surgery Centre was inaugurated early this year
Strategic partnership will develop a digital transformation roadmap and create opportunities for co-innovation in healthcare technologies
Successfully removed peanut from the child’s left lung through bronchoscopy
The key categories include intimate wellness, skincare & hair care
Investment with representation on the Board of Directors and technical know-how
The patient, who was previously diagnosed with osteoarthritis, was prescribed hip replacement surgery as the best and most effective solution for his condition
Subscribe To Our Newsletter & Stay Updated
